Literature DB >> 33277323

Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM.

Cong Xu1,2, Yanxing Wang1, Caixuan Liu1,2, Chao Zhang3, Wenyu Han1,2, Xiaoyu Hong1,2, Yifan Wang1,2, Qin Hong1,2, Shutian Wang1,2, Qiaoyu Zhao1,2, Yalei Wang3, Yong Yang3, Kaijian Chen1,2, Wei Zheng1,2, Liangliang Kong4, Fangfang Wang4, Qinyu Zuo1, Zhong Huang5, Yao Cong6,7.   

Abstract

The recent outbreaks and rapid international spread of SARS-CoV-2 pose a global health emergency. Its trimeric spike (S) glycoprotein interacts with human ACE2-receptor to mediate viral entry into host-cells. Here we present cryo-EM structures of a tightly closed SARS-CoV-2 S-trimer with packed fusion peptide, and an ACE2-bound S-trimer at 2.7 Å and 3.8 Å resolution, respectively. Accompanying ACE2 binding to the up receptor-binding domain (RBD), the associated ACE2-RBD exhibits continuous swing-motions within the S-trimer. Noteworthy, SARS-CoV-2 S-trimer appears much more sensitive to ACE2-receptor than SARS-CoV S-trimer regarding receptor-triggered transformation from the closed prefusion state to fusion-prone open state, potentially contributing to the superior infectivity of SARS-CoV-2. We defined the RBD T470-T478 loop and Y505 as viral determinants for specific recognition of SARS-CoV-2 RBD by ACE2. Our findings depict the mechanism of ACE2-induced S-trimer conformational transitions from ground prefusion state toward postfusion state, facilitating development of anti-SARS-CoV-2 vaccines and therapeutics.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Entities:  

Year:  2020        PMID: 33277323     DOI: 10.1126/sciadv.abe5575

Source DB:  PubMed          Journal:  Sci Adv        ISSN: 2375-2548            Impact factor:   14.136


  100 in total

1.  Selection analysis identifies unusual clustered mutational changes in Omicron lineage BA.1 that likely impact Spike function.

Authors:  Darren P Martin; Spyros Lytras; Alexander G Lucaci; Wolfgang Maier; Björn Grüning; Stephen D Shank; Steven Weaver; Oscar A MacLean; Richard J Orton; Philippe Lemey; Maciej F Boni; Houriiyah Tegally; Gordon Harkins; Cathrine Scheepers; Jinal N Bhiman; Josie Everatt; Daniel G Amoako; James Emmanuel San; Jennifer Giandhari; Alex Sigal; Carolyn Williamson; Nei-Yuan Hsiao; Anne von Gottberg; Arne De Klerk; Robert W Shafer; David L Robertson; Robert J Wilkinson; B Trevor Sewell; Richard Lessells; Anton Nekrutenko; Allison J Greaney; Tyler N Starr; Jesse D Bloom; Ben Murrell; Eduan Wilkinson; Ravindra K Gupta; Tulio de Oliveira; Sergei L Kosakovsky Pond
Journal:  bioRxiv       Date:  2022-01-18

Review 2.  Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection.

Authors:  Yu-Chyi Hwang; Ruei-Min Lu; Shih-Chieh Su; Pao-Yin Chiang; Shih-Han Ko; Feng-Yi Ke; Kang-Hao Liang; Tzung-Yang Hsieh; Han-Chung Wu
Journal:  J Biomed Sci       Date:  2022-01-04       Impact factor: 8.410

3.  Molecular basis of receptor binding and antibody neutralization of Omicron.

Authors:  Qin Hong; Wenyu Han; Jiawei Li; Shiqi Xu; Yifan Wang; Cong Xu; Zuyang Li; Yanxing Wang; Chao Zhang; Zhong Huang; Yao Cong
Journal:  Nature       Date:  2022-02-28       Impact factor: 49.962

4.  SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity.

Authors:  Annachiara Rosa; Valerie E Pye; Carl Graham; Luke Muir; Jeffrey Seow; Kevin W Ng; Nicola J Cook; Chloe Rees-Spear; Eleanor Parker; Mariana Silva Dos Santos; Carolina Rosadas; Alberto Susana; Hefin Rhys; Andrea Nans; Laura Masino; Chloe Roustan; Evangelos Christodoulou; Rachel Ulferts; Antoni G Wrobel; Charlotte-Eve Short; Michael Fertleman; Rogier W Sanders; Judith Heaney; Moira Spyer; Svend Kjær; Andy Riddell; Michael H Malim; Rupert Beale; James I MacRae; Graham P Taylor; Eleni Nastouli; Marit J van Gils; Peter B Rosenthal; Massimo Pizzato; Myra O McClure; Richard S Tedder; George Kassiotis; Laura E McCoy; Katie J Doores; Peter Cherepanov
Journal:  Sci Adv       Date:  2021-05-28       Impact factor: 14.136

5.  Structural dynamics of SARS-CoV-2 variants: A health monitoring strategy for anticipating Covid-19 outbreaks.

Authors:  Jacques Fantini; Nouara Yahi; Fodil Azzaz; Henri Chahinian
Journal:  J Infect       Date:  2021-06-03       Impact factor: 6.072

6.  Immunoinformatic analysis of structural and epitope variations in the spike and Orf8 proteins of SARS-CoV-2/B.1.1.7.

Authors:  Mushtaq Hussain; Sanya Shabbir; Anusha Amanullah; Fozia Raza; Muhammad J Imdad; Sahar Zahid
Journal:  J Med Virol       Date:  2021-03-25       Impact factor: 2.327

7.  The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein.

Authors:  Hisham M Dokainish; Suyong Re; Takaharu Mori; Chigusa Kobayashi; Jaewoon Jung; Yuji Sugita
Journal:  Elife       Date:  2022-03-24       Impact factor: 8.140

Review 8.  Cell entry by SARS-CoV-2.

Authors:  Ruchao Peng; Lian-Ao Wu; Qingling Wang; Jianxun Qi; George Fu Gao
Journal:  Trends Biochem Sci       Date:  2021-06-07       Impact factor: 13.807

9.  Landscape-Based Mutational Sensitivity Cartography and Network Community Analysis of the SARS-CoV-2 Spike Protein Structures: Quantifying Functional Effects of the Circulating D614G Variant.

Authors:  Gennady M Verkhivker; Steve Agajanian; Deniz Yasar Oztas; Grace Gupta
Journal:  ACS Omega       Date:  2021-06-09

Review 10.  The Spike of Concern-The Novel Variants of SARS-CoV-2.

Authors:  Anna Winger; Thomas Caspari
Journal:  Viruses       Date:  2021-05-27       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.